Gene · 10735
Papers2,605
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,605
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urine-Based Approaches for Screening, Diagnosis, and Surveillance of Urothelial Carcinoma. | J Pers Med | 2026 | 41893002 | PubTator, text mining | PubMed |
| Whole Lung Irradiation in Ewing Sarcoma with Pulmonary Metastases: Critical Appraisal of Evolution, Evidence, and Future Pathways in Precision Oncology. | Curr Treat Options Oncol | 2026 | 41880052 | PubTator, text mining | PubMed |
| Blocking heterochromatin spreading constrains cohesin binding at a yeast heterochromatic locus. | PLoS One | 2026 | 41875109 | PubTator, text mining | PubMed |
| Efficacy analysis of iptacopan in a patient with thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: a case report. | Front Immunol | 2026 | 41846930 | PubTator, text mining | PubMed |
| Case Report: Isolated acetabular myeloid sarcoma as the initial presentation of extramedullary blast crisis in chronic myeloid leukemia: a report of two cases and literature review. | Front Oncol | 2026 | 41836234 | PubTator, text mining | PubMed |
| BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | 41807883 | PubTator, text mining | PubMed |
| Sororin locks the DNA-exit gate of cohesin to preserve sister-chromatid cohesion. | Nat Commun | 2026 | 41807408 | PubTator, text mining | PubMed |
| Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changes. | Blood Neoplasia | 2026 | 41798677 | PubTator, text mining | PubMed |
| Prognostic impact of myelodysplasia-related gene mutations in ELN-2022 favorable-risk acute myeloid leukemia subtypes. | Ann Med | 2026 | 41797681 | PubTator, text mining | PubMed |
| Comparative genomic landscape of primary and metastatic bladder urothelial carcinoma in a large-scale cohort. | Int J Clin Oncol | 2026 | 41795757 | PubTator, text mining | PubMed |
| Validation of ICC hierarchical classification in secondary AML. | Blood Adv | 2026 | 41785326 | PubTator, text mining | PubMed |
| A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab. | JAAD Case Rep | 2026 | 41769072 | PubTator, text mining | PubMed |
| Inside the Battle Against Acute Myeloid Leukemia: Biology, Breakthroughs, and Hope. | Cells | 2026 | 41744781 | PubTator, text mining | PubMed |
| Prognostic implications of myelodysplasia-related gene mutations in NPM1-mutated acute myeloid leukemia: a systematic review and meta-analysis. | Haematologica | 2026 | 41742883 | PubTator, text mining | PubMed |
| Stilbenoid gaylussacin modulates particulate matter-induced chromatin remodeling in macrophages to suppress chronic obstructive pulmonary disease. | Signal Transduct Target Ther | 2026 | 41730844 | PubTator, text mining | PubMed |
| Chromosomal instability and chromosome 17p loss drive convergent NDE1 synthetic lethality in metastatic cancer cells. | bioRxiv | 2026 | 41727127 | PubTator, text mining | PubMed |
| Morphologic findings and mutational profiles of myelodysplastic neoplasms with normal versus abnormal karyotype. | J Hematop | 2026 | 41721060 | PubTator, text mining | PubMed |
| Myelodysplastic syndrome progress to acute myeloid leukemia: new insights and updates. | Front Immunol | 2026 | 41716386 | PubTator, text mining | PubMed |
| Biomarkers and advances in AML-MRC: from bench to bedside. | Ann Hematol | 2026 | 41711916 | PubTator, text mining | PubMed |
| A novel NMD-escaping STAG2 variant associated with syndromic neurodevelopmental delay, growth failure, and distinctive dysmorphism: expanding the phenotype in male patients and literature review. | Gene | 2026 | 41692185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10735/papers?page=3